Axis and Suan Biotech back Noscira

The investment, which forms part of the capital increase announced by the firm in September 2010, was partly channelled via the Fondo FESpyme which Axis advises.

Noscira, which specialises in the research and development of Alzheimer's treatments, was founded in 2000 and employs 67 staff.

The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.

If you have any information regarding this transaction, please contact Susannah Birkwood on +44 20 7004 7524 or susannah.birkwood@incisivemedia.com

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Southern Europe
• Healthcare
• Expansion
• Spain